• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水性氨基酸侧链在 CFTR 氯离子通道电导和选择性的狭窄选择性滤器中的作用。

Role of Hydrophobic Amino-Acid Side-Chains in the Narrow Selectivity Filter of the CFTR Chloride Channel Pore in Conductance and Selectivity.

机构信息

Department of Physiology & Biophysics, Dalhousie University, PO Box 15000, Halifax, NS, B3H 4R2, Canada.

出版信息

J Membr Biol. 2023 Dec;256(4-6):433-442. doi: 10.1007/s00232-023-00294-w. Epub 2023 Oct 12.

DOI:10.1007/s00232-023-00294-w
PMID:37823914
Abstract

Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. Structural analysis of CFTR has identified a narrow, hydrophobic region close to the extracellular end of the open channel pore that may function as a selectivity filter. The present study combines comprehensive mutagenesis of hydrophobic amino-acid side-chains within the selectivity filter with functional evaluation of channel Cl conductance and anion selectivity. Among these hydrophobic amino-acids, one (F337) appears to play a dominant role in determining both conductance and selectivity. Anion selectivity appears to depend on both side-chain size and hydrophobicity at this position. In contrast, conductance is disrupted by all F337 mutations, suggesting that unique interactions between permeating Cl ions and the native phenylalanine side-chain are important for conductance. Surprisingly, a positively charged lysine side-chain can be substituted for several hydrophobic residues within the selectivity filter (including F337) with only minor changes in pore function, arguing against a crucial role for overall hydrophobicity. These results suggest that localized interactions between permeating anions and amino-acid side-chains within the selectivity filter may be more important in determining pore functional properties than are global features such as overall hydrophobicity.

摘要

囊性纤维化是由囊性纤维化跨膜电导调节因子(CFTR)阴离子通道中的突变引起的。CFTR 的结构分析确定了靠近开放通道孔的细胞外端的狭窄疏水区,该区域可能作为选择性过滤器发挥作用。本研究结合了对选择性过滤器中疏水性氨基酸侧链的综合诱变与通道 Cl 电导和阴离子选择性的功能评估。在这些疏水性氨基酸中,一个(F337)似乎在确定电导和选择性方面都起着主导作用。阴离子选择性似乎取决于该位置的侧链大小和疏水性。相比之下,所有 F337 突变都会破坏电导,这表明穿透 Cl 离子与天然苯丙氨酸侧链之间的独特相互作用对于电导很重要。令人惊讶的是,带正电荷的赖氨酸侧链可以取代选择性过滤器中的几个疏水性残基(包括 F337),而对孔功能的影响很小,这表明总体疏水性的作用不大。这些结果表明,在确定孔功能特性方面,穿透阴离子与选择性过滤器中氨基酸侧链之间的局部相互作用可能比整体特征(如总体疏水性)更为重要。

相似文献

1
Role of Hydrophobic Amino-Acid Side-Chains in the Narrow Selectivity Filter of the CFTR Chloride Channel Pore in Conductance and Selectivity.疏水性氨基酸侧链在 CFTR 氯离子通道电导和选择性的狭窄选择性滤器中的作用。
J Membr Biol. 2023 Dec;256(4-6):433-442. doi: 10.1007/s00232-023-00294-w. Epub 2023 Oct 12.
2
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
3
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.用于囊性纤维化相关肺部疾病的局部囊性纤维化跨膜传导调节因子基因替代疗法。
Cochrane Database Syst Rev. 2016 Jun 17;2016(6):CD005599. doi: 10.1002/14651858.CD005599.pub5.
4
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.依伐卡托(Ataluren)及类似化合物(针对 I 类提前终止密码子突变的特异性治疗药物)治疗囊性纤维化。
Cochrane Database Syst Rev. 2023 Mar 3;3(3):CD012040. doi: 10.1002/14651858.CD012040.pub3.
5
Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore.囊性纤维化跨膜传导调节因子氯离子通道孔中阴离子选择性的分子决定因素。
Biophys J. 2000 Jun;78(6):2973-82. doi: 10.1016/S0006-3495(00)76836-6.
6
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.用于治疗囊性纤维化的阿他芦醇及类似化合物(针对I类提前终止密码子突变的特定疗法)。
Cochrane Database Syst Rev. 2017 Jan 19;1(1):CD012040. doi: 10.1002/14651858.CD012040.pub2.
7
Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.气道清除技术与囊性纤维化的非气道清除技术比较。
Cochrane Database Syst Rev. 2023 Apr 12;4(4):CD001401. doi: 10.1002/14651858.CD001401.pub4.
8
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.12岁及以上囊性纤维化患者使用万扎卡托-替扎卡托-地替瓦卡托与依列卡托-替扎卡托-艾伐卡托的对比研究(SKYLINE试验VX20 - 121 - 102和VX20 - 121 - 103):两项随机、活性对照3期试验的结果
Lancet Respir Med. 2025 Mar;13(3):256-271. doi: 10.1016/S2213-2600(24)00411-9. Epub 2025 Jan 2.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Molecular dynamics study of Cl permeation through cystic fibrosis transmembrane conductance regulator (CFTR).氯离子通过囊性纤维化跨膜电导调节蛋白(CFTR)渗透的分子动力学研究。
Cell Mol Life Sci. 2023 Jan 24;80(2):51. doi: 10.1007/s00018-022-04621-7.
2
Cystic fibrosis.囊性纤维化。
Lancet. 2021 Jun 5;397(10290):2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
3
Two positively charged amino acid side-chains in the inner vestibule of the CFTR channel pore play analogous roles in controlling anion binding and anion conductance.
CFTR 通道孔内腔的两个带正电荷的氨基酸侧链在控制阴离子结合和阴离子电导方面起着类似的作用。
Cell Mol Life Sci. 2021 Jun;78(12):5213-5223. doi: 10.1007/s00018-021-03859-x. Epub 2021 May 23.
4
Discovering the chloride pathway in the CFTR channel.发现 CFTR 通道中的氯离子通道。
Cell Mol Life Sci. 2020 Feb;77(4):765-778. doi: 10.1007/s00018-019-03211-4. Epub 2019 Jul 20.
5
Contribution of the eighth transmembrane segment to the function of the CFTR chloride channel pore.第八跨膜片段对 CFTR 氯离子通道孔功能的贡献。
Cell Mol Life Sci. 2019 Jun;76(12):2411-2423. doi: 10.1007/s00018-019-03043-2. Epub 2019 Feb 13.
6
STRUCTURE, GATING, AND REGULATION OF THE CFTR ANION CHANNEL.CFTR 阴离子通道的结构、门控和调节。
Physiol Rev. 2019 Jan 1;99(1):707-738. doi: 10.1152/physrev.00007.2018.
7
Molecular structure of the ATP-bound, phosphorylated human CFTR.ATP 结合磷酸化的人 CFTR 的分子结构。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12757-12762. doi: 10.1073/pnas.1815287115. Epub 2018 Nov 20.
8
Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure.囊性纤维化跨膜电导调节因子(CFTR):从活性转运体结构中构建离子通道。
Channels (Austin). 2018;12(1):284-290. doi: 10.1080/19336950.2018.1502585.
9
Combining theoretical and experimental data to decipher CFTR 3D structures and functions.结合理论和实验数据来破解 CFTR 的三维结构和功能。
Cell Mol Life Sci. 2018 Oct;75(20):3829-3855. doi: 10.1007/s00018-018-2835-7. Epub 2018 May 19.
10
Structural mechanisms of CFTR function and dysfunction.CFTR 功能和失能的结构机制。
J Gen Physiol. 2018 Apr 2;150(4):539-570. doi: 10.1085/jgp.201711946. Epub 2018 Mar 26.